Pharmaceutical Business Review
Return to: PBR Home | Companies

ArQule Inc

ArQule Inc
One Wall Street
Burlington
United States of America
Phone: 1 781 9940300
Fax: 17-81-3766019
www.arqule.com

No. employees: 32
Turnover: 00.00 (US$m)
Financial year end: December

Company Overview

Top Competitors


Key Employees

Paolo Pucci

Director, Chief Executive Officer, Executive Board

Patrick J. Zenner

Chairman, Executive Board

Michael D. Loberg, Ph.D.

Director, Non Executive Board

Ronald M. Lindsay, Ph.D.

Director, Non Executive Board

Timothy C. Barabe

Director, Non Executive Board

Susan L. Kelley, M.D.

Director, Non Executive Board

William G. Messenger

Director, Non Executive Board

Ran Nussbaum

Director, Non Executive Board

Peter S. Lawrence

Chief Operating Officer, President, Senior Management

Brian Schwartz

Chief Medical Officer, Senior Management

Robert J. Weiskopf

Chief Financial Officer, Treasurer, Senior Management

Marc Schegerin

Senior Vice President - Corporate Strategy, Communication and Finance, Senior Management

Shirish Hirani

Senior Vice President - Program Management and Product Planning, Senior Management

Locations/Subsidiaries


One Wall Street,
Burlington,
Massachusetts,
United States of America
Phone: 1 781 9940300
Fax: 1 781 3766019

Products/Services


Products:

  • Pipeline
  • Tivantinib (ARQ 197)
  • ARQ 092 Akt Inhibitor
  • ARQ 087 Multi-Kinase Inhibitor with Pan-FGFR Activity
  • ARQ 761 a Potential NQ01 Inhibitor
  • ARQ 751 an Akt Inhibitor
  • ARQ 531